2020 Cancer Screening Rates Low at Federally Qualified Health Centers
Rates for breast, cervical, and colorectal cancer screening well below the general population in 2020
GWAS Identifies 108 Independent Risk Loci for Kidney Cancer
Validated polygenic risk score generated, with area under the curve of 0.65 among European ancestry individuals
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Recombinant ADAMTS13 Effective, Safe in Congenital Thrombotic Thrombocytopenic Purpura
Treatment had few adverse events and increased ADAMTS13 activity versus standard therapy
Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
Hormone therapy no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation no aid for universal fracture prevention
EPA Earmarks $3 Billion to Replace Lead Pipes Nationwide
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death
Optimal healthy lifestyles include never smoking, regular physical activity, adequate sleep duration, and a healthy diet
Biden Administration Could Reclassify Marijuana as Less Risky Drug
USPSTF Recommends Breast Cancer Screening for Women Aged 40 to 75 Years
Insufficient evidence seen for screening older women and for supplemental screening for women with dense breasts
